HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Ayush 64

contains extracts from Kiratatikta (Swertia chirata), Katuki (Picrorhiza kurroa), Saptaparna (Alstonia scholaris), and Kuberaksha (Caesalpinia cristata)

Also Known As:

Ayush-64

Networked: 17 relevant articles (5 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Ayush 64: 17
Pharmaceutical Preparations
- Plant Extracts: 3916
  - Ayush 64: 17

Experts

1.	Khanduri, Shruti: 5 articles (06/2022 - 04/2020)
2.	Rana, Rakesh: 4 articles (06/2022 - 04/2020)
3.	Srikanth, N: 4 articles (04/2022 - 01/2022)
4.	Chandrasekhararao, Bhogavalli: 3 articles (06/2022 - 04/2020)
5.	Singhal, Richa: 3 articles (06/2022 - 01/2022)
6.	Srikanth, Narayanam: 3 articles (06/2022 - 04/2020)
7.	Yadav, Babita: 3 articles (06/2022 - 04/2020)
8.	Rai, Amit Kumar: 3 articles (04/2022 - 04/2020)
9.	Dhiman, K S: 3 articles (01/2022 - 01/2022)
10.	Jameela, Sophia: 2 articles (06/2022 - 04/2020)

Related Diseases

1.	COVID-19 06/01/2022 - "To determine the therapeutic efficacy and safety of AYUSH-64 as an add-on to standard care in mild to moderate COVID-19. " 06/01/2022 - "AYUSH-64 as adjunct to standard care is safe and effective in hastening clinical recovery in mild to moderate COVID-19. " 01/01/2023 - "AYUSH 64 in combination with SOC hastened recovery, reduced hospitalization, and improved health in COVID-19. " 01/01/2023 - "Evaluate the efficacy of AYUSH 64, a standard polyherbal Ayurvedic drug in COVID-19. " 04/01/2022 - "This review will highlight the specifications of AYUSH-64, its mechanism of action, its repurposing for COVID-19, various clinical and experimental studies."
2.	Virus Diseases (Viral Diseases) 01/01/2022 - "AYUSH 64 along-with standard care in ILI is safe and efficacious and this may be used in other viral infections with pyrexia as add-on to standard care for early recovery and better outcome."
3.	Fever (Fevers) 01/01/2022 - "AYUSH-64, a poly-herbal drug, is in practice for 40 years for various clinical conditions like fevers, microfilaremia, and inflammatory conditions. " 01/01/2022 - "AYUSH 64 along-with standard care in ILI is safe and efficacious and this may be used in other viral infections with pyrexia as add-on to standard care for early recovery and better outcome."
4.	Severe Acute Respiratory Syndrome 01/01/2022 - "Thus, the present study was undertaken to evaluate AYUSH-64 compounds available in this drug against Severe Acute Respiratory Syndrome-Corona Virus (SARS-CoV-2) Main Protease (Mpro; PDB ID: 6LU7) via in silico techniques. "
5.	Human Influenza (Influenza) 01/01/2022 - "Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'." 01/01/2022 - "AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study." 01/01/2022 - "Influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation." 07/01/2022 - "Ayurveda herbal formulation AYUSH-64, proven to treat malaria and influenza-like illness in india was repurposed for COVID-19 patients considering preliminary evidances, however, scientific data was not available. "

Related Drugs and Biologics

1.	Interleukin-6 (Interleukin 6)
2.	Cytochrome P-450 CYP2C8
3.	Cytochrome P-450 CYP3A
4.	Cytochrome P-450 CYP2D6 (CYP2D6)
5.	Peptide Hydrolases (Proteases)
6.	Oxides
7.	Enzymes
8.	akuammicine
9.	Ashwagandha
10.	remdesivir

Related Therapies and Procedures

1.	Patient Isolation
2.	Mechanical Ventilators (Ventilator)